Skip to content

IPHYF

Innate Pharma SA

Healthcare · Biotechnology · FR

Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue6.2M2.8M12.6M51.9M57.7M
Cost of Revenue(8.6M)52.0M56.0M51.7M
Gross Profit32.1M2.8M12.6M5.6M6.0M
Operating Expenses
R&D Expense66.4M43.6M52.0M56.0M51.7M
SG&A Expense20.8M11.0M11.9M11.7M14.5M
General & Admin Expense13.5M11.0M11.6M11.4M13.9M
Selling & Marketing Expense(164.0K)309.0K316.0K530.0K
Other Expenses48.0M1.6M283.0K(49.5M)(2.7M)
Total Operating Expenses135.2M56.2M64.2M18.3M63.4M
Cost and Expenses106.8M56.2M64.2M74.3M115.1M
Operating Income (EBIT)(100.5M)(53.4M)(51.6M)(12.7M)(57.4M)
Non-Operating
Interest Income8.1M1.3M2.4M3.2M546.0K
Interest Expense3.1M440.0K566.0K640.0K288.0K
Net Interest Income4.7M878.0K1.9M2.5M258.0K
Other Non-Op Income/Expense4.2M4.2M2.1M5.1M(547.0K)
Non-Operating Income (excl Interest)(2.7M)(4.7M)(2.7M)(5.7M)259.0K
EBT (Pre-Tax Income)(96.4M)(49.2M)(49.5M)(7.6M)(58.0M)
Income Tax Expense(5.6M)
Bottom Line
Net Income(93.6M)(49.2M)(49.5M)(7.6M)(58.1M)
Earnings from Cont. Ops(93.6M)(49.2M)(49.5M)(7.6M)(58.0M)
Earnings from Discont. Ops(131.0K)
Bottom Line Net Income(93.8M)(49.2M)(49.5M)(7.6M)(58.1M)
Per Share
Basic EPS($1.06)($0.53)($0.61)($0.09)($0.73)
Diluted EPS($1.06)($0.53)($0.61)($0.09)($0.73)
Revenue Per Share$0.07$0.03$0.16$0.62$0.72
Shares
Basic Shares Outstanding93.8M89.4M81.1M84.1M79.6M
Diluted Shares Outstanding93.8M89.4M81.1M84.1M79.6M
Profitability Metrics
EBITDA(99.0M)(43.6M)(46.9M)(1.8M)(12.3M)
D&A2.9M5.1M2.0M5.1M45.4M
EBIT(101.2M)(48.7M)(48.9M)(6.9M)(57.7M)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026